KRAS and colorectal carcinoma: Mutations at residues 12 and 13 of KRAS, which are associated with CRC metastasis, occurred with significantly higher frequency in the present study (38% of cases) than in the TCGA dataset (13.11% and 7.52% respectively), but within the midrange of KRAS mutation frequencies observed in CRC cohorts worldwide [41].